K2 Principal Fund’s Peak Bio, Inc. Warrant PKBOW Stock Holding History

K2 Principal Fund’s Portfolio PKBOW Stock Details PKBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-441,409	Closed	-$66K	–	383
2022 Q2	$66K	Hold	441,409	–	–	0.01%	263
2022 Q1	$187K	Hold	441,409	–	–	0.02%	203
2021 Q4	$322K	Buy	441,409 +29,000	+7%	+$21.3K	0.02%	253
2021 Q3	$264K	Buy	+412,409	New	+$328K	0.02%	240

Other funds holding PKBOW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CCFM

Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return

K2 Principal Fund's PKBOW Position: Q3 2022 in Review

K2 Principal Fund sold out of Peak Bio, Inc. Warrant (PKBOW) in Q3 2022, closing a stake of 441,409 shares — an estimated $66K sold.

K2 Principal Fund first reported a position in PKBOW in Q3 2021 and held it in 4 quarters. The position peaked at $322K in Q4 2021. 17 funds tracked by Wall St. Rank hold PKBOW as of Q3 2022.

K2 Principal Fund reported no remaining Peak Bio, Inc. Warrant position as of Q3 2022 after selling out during the quarter.
K2 Principal Fund sold 441,409 Peak Bio, Inc. Warrant shares in Q3 2022, an estimated $66K.
K2 Principal Fund first reported a position in Peak Bio, Inc. Warrant in Q3 2021 and held it in 4 quarters.
K2 Principal Fund's Peak Bio, Inc. Warrant position peaked at $322K in Q4 2021.
17 funds tracked by Wall St. Rank held Peak Bio, Inc. Warrant as of Q3 2022.

Based on K2 Principal Fund's 13F filing for Q3 2022, filed 14 Nov 2022.